24.05 16:06 | dpa-AFX: Lilly Increases Investment In Indiana-Based Unit To Enhance Production Of Zepbound, Mounjaro |
24.05 15:36 | dpa-AFX: *ELI LILLY INVESTS ADDITIONAL $1.2 BLN TO UPGRADE INDIANAPOLIS FACILITIES AND WISCONSIN MANUFACTURING SITE |
24.05 15:34 | dpa-AFX: *LILLY DOUBLES INVESTMENT IN LEBANON, INDIANA SITE WITH NEW $5.3 BLN COMMITMENT |
21.05 15:13 | dpa-AFX: Lilly Reports Positive Phase 3 Trial Results Of Mirikizumab In Crohn's Disease |
21.05 14:04 | dpa-AFX: *LILLY'S MIRIKIZUMAB SHOWS POSITIVE RESULTS: OVER HALF OF CROHN'S PATIENTS ACHIEVE REMISSION, EVEN AFTER BIOLOGIC FAILURE |
16.05 15:32 | dpa-AFX: Lilly Says Phase 3 Trials Of Once-weekly Insulin In Type 2 Diabetes Meets Primary Endpoint |
16.05 13:48 | dpa-AFX: *LILLY : PHASE 3 TRIALS OF ONCE-WEEKLY INSULIN IN TYPE 2 DIABETES MEETS PRIMARY ENDPOINT |
16.05 11:40 | dpa-AFX: ROUNDUP: Roche erreicht ersten Studienerfolg bei Fettleibigkeit - Aktie legt zu |
16.05 11:40 | ROUNDUP: Roche erreicht ersten Studienerfolg bei Fettleibigkeit - Aktie legt zu |
16.05 11:35 | dpa-AFX: ROUNDUP: Roche erreicht ersten Studienerfolg bei Fettleibigkeit - Aktie legt zu |
15.05 14:04 | dpa-AFX: *LILLY: ALONZO WEEMS TO RETIRE AS EVP OF ENTERPRISE RISK MANAGEMENT AND CHIEF ETHICS AND COMPLIANCE OFFICER |
07.05 17:28 | dpa-AFX: FDA Advisory Committee To Convene Meeting To Discuss On Eli Lilly's Alzheimer's Drug |
07.05 17:09 | dpa-AFX: *FDA ADVISORY COMMITTEE TO REVIEW ELI LILLY'S DONANEMAB FOR EARLY ALZHEIMER'S TREATMENT |
06.05 17:41 | dpa-AFX: *ELI LILLY AND CO. (LLY) DECLARES $ 1.30 DIVIDEND FOR Q2 24, RECORD DATE 5/16/2024 |
06.05 17:38 | dpa-AFX: *LILLY DECLARES Q2 DIVIDEND OF $1.30/SHARE, PAYABLE JUNE 10/ RECORD MAY 16 |
02.05 15:17 | dpa-AFX: *DZ BANK CUTS FAIR VALUE FOR ELI LILLY TO 800 (820) USD - 'HOLD' |
02.05 15:17 | dpa-AFX: *DZ BANK SENKT FAIREN WERT FÜR ELI LILLY AUF 800 (820) USD - 'HALTEN' |
01.05 06:00 | dpa-AFX: *WDH/JEFFERIES HEBT ZIEL FÜR ELI LILLY AUF 915 (895) USD - 'BUY' |
01.05 06:00 | dpa-AFX: *RPT/JEFFERIES RAISES ELI LILLY PRICE TARGET TO 915 (895) USD - 'BUY' |
30.04 22:09 | MÄRKTE USA/Anleger bekommen vor Fed-Auftritt kalte Füße |
|